Fetomaternal Outcome of Thrombocytopenia in Pregnancy
DOI:
https://doi.org/10.22376/ijlpr.v16i3.2057Keywords:
Thrombocytopenia, Pregnancy, Gestational thrombocytopenia, Immune thrombocytopenic purpura, Maternal outcome, Fetal outcomeAbstract
Pregnancy is associated with substantial physiological adaptation of the maternal haematological system, and even minor deviations in platelet count can affect both maternal and fetal well-being. Thrombocytopenia, defined as a platelet count below 150,000/µL, is the second most common haematological abnormality in pregnancy after anaemia, with reported prevalence ranging from 6.6% to 11.6%. While gestational thrombocytopenia is the most frequent and benign cause, other aetiologies such as immune thrombocytopenic purpura, preeclampsia, HELLP syndrome, acute fatty liver of pregnancy and infections can indicate serious systemic disease and adversely affect outcomes. This prospective case-control study was undertaken to identify the aetiological factors responsible for thrombocytopenia in pregnancy and to evaluate its maternal and fetal outcomes. The study was conducted in the Department of Obstetrics and Gynaecology, B. J. Medical College and Civil Hospital, Ahmedabad, over a period of two years (October 2023-October 2025). One hundred antenatal women were enrolled, comprising 50 women with thrombocytopenia (platelet count <150,000/µL) as cases and 50 women with normal platelet counts as controls, and were followed prospectively till delivery. Gestational thrombocytopenia was the commonest cause (52%), followed by immune thrombocytopenic purpura (20%), viral infections (12%), preeclampsia (8%), HELLP syndrome (6%) and acute fatty liver of pregnancy (2%). Moderate thrombocytopenia was the most frequent severity category (50%). Women with thrombocytopenia had a significantly earlier mean gestational age at delivery, a higher requirement for blood product transfusion, and a higher rate of pancytopenia compared with controls. Fetal and neonatal outcomes, including low birth weight, preterm birth, intrauterine growth restriction, NICU admission, intrauterine death and perinatal mortality, were all significantly worse among women with thrombocytopenia. Maternal complications such as abruption, postpartum haemorrhage and disseminated intravascular coagulation were more frequent among cases, although the difference did not reach statistical significance. This study confirms that thrombocytopenia in pregnancy, though frequently due to a benign gestational cause, is associated with a significantly increased risk of adverse maternal and, more prominently, fetal outcomes, underscoring the need for early aetiological diagnosis, close antenatal surveillance and multidisciplinary management to optimise outcomes for both mother and baby.
References
Cunningham FG, Leveno KJ, Bloom SL, Dashe JS, Hoffman BL, Casey BM, et al. Williams Obstetrics. 26th ed. New York: McGraw Hill; 2022.
Boehlen F, Hohlfeld P, Extermann P, Perneger T, de Moerloose P. Platelet count at term pregnancy: a reappraisal of the threshold. Obstet Gynecol. 2000;95(1):29-33.
Reese JA, Peck JD, Deschamps DR, McIntosh JJ, Knudtson EJ, Terrell DR, et al. Platelet counts in women with normal pregnancies and pregnancies complicated by thrombocytopenia. N Engl J Med. 2018;379(1):32-43.
Burrows RF, Kelton JG. Thrombocytopenia at delivery: a prospective survey of 6715 deliveries. Am J Obstet Gynecol. 1990;162(3):731-734.
American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 207: Thrombocytopenia in pregnancy. Obstet Gynecol. 2019;133(3):e181-e193.
Cines DB, Levine LD. Thrombocytopenia in pregnancy. Blood. 2017;130(21):2271-2277.
Gerner P, et al. The differential diagnosis of thrombocytopenia in pregnancy. DtschArztebl Int. 2015;112(47):795-802.
Zufferey A, Kapur R, Semple JW. Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP). J Clin Med. 2017;6(2):16.
Neunert C, Terrell DR, Arnold DM, Buchanan G, Cines DB, Cooper N, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3(23):3829-3866.
Petca A, Miron BC, Pacu I, Dumitrascu MC, Mehedintu C, Sandru F, et al. HELLP syndrome-holistic insight into pathophysiology. Medicina. 2022;58(2):326.
Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol. 1993;169(4):1000-1006.
Bisson C, Dautel S, Patel E, Suresh S, Dauer P, Rana S. Preeclampsia pathophysiology and adverse outcomes during pregnancy and postpartum. Front Med. 2023;10:1144170.
Khazali AS, Hadrawi WH, Ibrahim F, Othman S, Rashid NN. Thrombocytopenia in dengue infection: mechanisms and a potential application. J Trop Med Int Health. 2024. Epub ahead of print.
Gehlot H, Yadav OP, Sharma S, Nagar GG, Yadav A, Gupta PP. A study of dengue fever in pregnancy and its maternal and fetal prognosis. Int J Reprod Contracept Obstet Gynecol. 2017;6(8):3414-3417.
Pishko AM, Marshall AL. Thrombocytopenia in pregnancy. Hematology Am Soc HematolEduc Program. 2022;2022(1):303-311.
Fogerty AE. Thrombocytopenia in pregnancy: approach to diagnosis and management. Semin ThrombHemost. 2020;46(3):256-263.
Gernsheimer T, et al. Thrombocytopenia in pregnancy: approach to diagnosis and management. Semin ThrombHemost. 2020;46(3):256-263.
Kuwabara Y, et al. Impact of thrombocytopenia on postpartum hemorrhage in pregnant women: a retrospective cohort study. J ObstetGynaecol Res. 2016.
Pishko AM, Levine LD, Cines DB. Thrombocytopenia in pregnancy: diagnosis and approach to management. Blood Rev. 2020;40:100638.
Samuels P, Bussel JB, Braitman LE, Tomaski A, Druzin ML, Mennuti MT, Cines DB. Estimation of the risk of thrombocytopenia in the offspring of pregnant women with idiopathic thrombocytopenic purpura. N Engl J Med. 1990;323(4):229-235.
Semple JW, Italiano JE Jr, Freedman J. Platelets: envoys at the infection frontline. J Infect Dis. 2013;208(6):895-903.
Myers B. Thrombocytopenia in pregnancy. ObstetGynaecol. 2009;11(3):177-183.
Begam A, Sujatha TL, Nambisan B, Vasanthakumari KP. Risk factors of thrombocytopenia in pregnancy. Int J Reprod Contracept Obstet Gynecol. 2017;6:700-706.
Singh J, Kumari K, Verma V. Study of thrombocytopenia in pregnancy: clinical presentation and outcome at tertiary care rural institute. Int J Reprod Contracept Obstet Gynecol. 2020;9:1622-1626.
Harde M, Bhadade R, deSouza R, Jhingan M. Thrombocytopenia in pregnancy nearing term: a clinical analysis. Indian J Crit Care Med. 2019;23(11):503-508.
Prajapati S, Kumar NPS. A study on thrombocytopenia in pregnancy and feto-maternal outcome conducted at tertiary care center Rajkot, Gujarat. Int J Reprod Contracept Obstet Gynecol. 2023;12:1350-1355.
Singh N. Prevalence and characterization of thrombocytopenia in pregnancy in Indian women. Indian J Hematol Blood Transfus. 2011;28(2):77-81.
Katke RD, Gohil DP. Thrombocytopenia during pregnancy: an institutional based study. Int J Reprod Contracept Obstet Gynecol. 2014;3(4):947-951.
Roy M, Kyal A, Donga P, Das I. Thrombocytopenia in pregnancy and its correlation with fetomaternal outcome in a tertiary care hospital. Nep J Obstet Gynecol. 2022;17(34):23-27.
Parnas M, Sheiner E, Shoham-Vardi I, Burstein E, Yermiahu T, Levi I, et al. Moderate to severe thrombocytopenia during pregnancy. Eur J ObstetGynecolReprod Biol. 2006;128(1-2):163-168.
Deo S, Pandey A, Kumari P, Ahamad MK. Evaluation of etiological factors of thrombocytopenia in pregnancy and its effects on feto-maternal outcomes. Int J Pharm Clin Res. 2023;15(10):64-75.
Arora M, Goyal L, Khutan H. Prevalence of thrombocytopenia during pregnancy & its effect on pregnancy & neonatal outcome. Ann Int Med Dent Res. 2017;3(2):ME04-ME06.
Modi K, Chaudhari J, Vaja D. A study of thrombocytopenia in pregnancy. Int J Reprod Contracept Obstet Gynecol. 2020;9:1115-1118.
Vanaja S, Mahalaxmi, Sundari T. Evaluation of thrombocytopenia in pregnancy; its effects on maternal and fetal outcome. MedPulse Int J Gynaecol. 2017;4(2):31-36.
Usha S, Renuka P, Vandana P. Prospective study of thrombocytopenia in pregnancy and its effect on maternal and foetal outcome. J Evid Based Med Healthc. 2016;3(82):4463-4469.
Dwivedi P, Puri M, Nigam A, Agarwal K. Fetomaternal outcome in pregnancy with severe thrombocytopenia. Eur Rev Med Pharmacol Sci. 2012;16:1563-1566.
Kamphuis MM, et al. Severe thrombocytopenia and microangiopathic hemolyticanemia in pregnancy: a guide for the consulting hematologist. Am J Hematol. 2021;96(12):1655-1665.
Katherashala A, Goli M, Sripathi A, Vamsheepriya P. Study of thrombocytopenia in pregnancy. J Cardiovasc Dis Res. 2023;14(7):2215-2228.
Kumari R, Sharma M, Rajkumar. Maternal and fetal outcome among pregnant women presenting with thrombocytopenia. Int J Clin ObstetGynaecol. 2022;6(5):16-19.
Webert KE, Mittal R, Sigouin C, Heddle NM, Kelton JG. A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura. Blood. 2003;102(13):4306-4311.
Care A, Pavord S, Knight M, Alfirevic Z. Severe primary autoimmune thrombocytopenia in pregnancy: a national cohort study. BJOG. 2018;125(5):604-612.
Michel M, et al. Thrombopoietin receptor agonist for treatment of immune thrombocytopenia in pregnancy: a narrative review. Ther Adv Hematol. 2021;12:20406207211001139.
McCrae KR. Managing ITP and thrombocytopenia in pregnancy. Platelets. 2020;31(3):300-306.
Varghese S, Kour G, Dhar T. Thrombocytopenia in pregnancy in a tertiary care hospital: a retrospective study. Int J Reprod Contracept Obstet Gynecol. 2016;5:1532-1535.
Thapliyal M, Choudhary A, Choudhary D, Gupta V. To study feto-maternal outcome in pregnancy with thrombocytopenia. J ObstetGynecol Cancer Res. 2025;10(4):307-314.
Sumathy V, Devi C, Padmanaban S. Prospective study of thrombocytopenia in pregnancy. Int J Clin ObstetGynaecol. 2019;3(1):17-21.
Park YH. Diagnosis and management of thrombocytopenia in pregnancy. Blood Res. 2022;57(S1):79-85.
Published
How to Cite
Issue
Section

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

